Parion Lands Monster Deal With Gilead For Cystic Fibrosis Candidate
This article was originally published in The Pink Sheet Daily
Executive Summary
With another CF candidate in Phase III, Gilead looks to build a respiratory disease franchise, R&D chief tells “The Pink Sheet” DAILY.